Changes of retinal ganglion cell–inner plexiform layer thickness and visual acuity in patients with diabetic macular edema treated with Aflibercept
Background Anti-vascular endothelial growth factor agents have now become the first line of treatment for diabetic macular edema (DME). Changes in the thickness of the individual retinal layers including the ganglion cell–inner plexiform layer (GC–IPL) might serve as a biomarker for the response to...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Delta Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/djo.djo_51_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849393964531056640 |
|---|---|
| author | Mouna M. Alsaad Amin B. Shehadeh Iyman M. Alsaad Khalid A. Alubous Jehad S. Meqbil Mohammed Z. Qablawi Saif Aldeen S. AIRyalat Rawan A. Elubous |
| author_facet | Mouna M. Alsaad Amin B. Shehadeh Iyman M. Alsaad Khalid A. Alubous Jehad S. Meqbil Mohammed Z. Qablawi Saif Aldeen S. AIRyalat Rawan A. Elubous |
| author_sort | Mouna M. Alsaad |
| collection | DOAJ |
| description | Background
Anti-vascular endothelial growth factor agents have now become the first line of treatment for diabetic macular edema (DME). Changes in the thickness of the individual retinal layers including the ganglion cell–inner plexiform layer (GC–IPL) might serve as a biomarker for the response to treatment.
Aim
The aim of this study was to evaluate the effect of intravitreal injections of Aflibercept on the average thicknesses of the GC–IPL in naïve eyes and on the visual acuity in patients with DME.
Patients and methods
This is a retrospective observational study that included 224 naïve eyes of 224 patients having DME. It compared the changes in the GC–IPL thickness at baseline and after receiving three loading doses of Aflibercept followed by as needed protocol for 12 months. All patients had optical coherence tomography imaging at baseline (with GC–IPL thickness measurement) and at the 12-month visit. The change in GC–IPL thickness was measured and was correlated with best-corrected visual acuity.
Results
During the study duration, a median of five injections of Aflibercept were given. There was a statistically significant decrease in the posttreatment values of the GC–IPL thickness from 89±13 to 84±14.7 µm (P=0.029). Moreover, a statistically significant association was found between the thickness reduction of the GC–IPL in the central macular area and the best-corrected visual acuity (r=0.9, P=0.005, Pearson coefficient=0.26).
Conclusion
The results of this study suggest that the reduction in the GC–IPL thickness can be used as a prognostic tool for the response to Aflibercept as it was associated with improved visual acuity. |
| format | Article |
| id | doaj-art-8c3f3dab277548a486d5ae5d45f90e37 |
| institution | Kabale University |
| issn | 1110-9173 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Delta Journal of Ophthalmology |
| spelling | doaj-art-8c3f3dab277548a486d5ae5d45f90e372025-08-20T03:40:14ZengWolters Kluwer Medknow PublicationsDelta Journal of Ophthalmology1110-91732025-01-01261202510.4103/djo.djo_51_24Changes of retinal ganglion cell–inner plexiform layer thickness and visual acuity in patients with diabetic macular edema treated with AfliberceptMouna M. AlsaadAmin B. ShehadehIyman M. AlsaadKhalid A. AlubousJehad S. MeqbilMohammed Z. QablawiSaif Aldeen S. AIRyalatRawan A. ElubousBackground Anti-vascular endothelial growth factor agents have now become the first line of treatment for diabetic macular edema (DME). Changes in the thickness of the individual retinal layers including the ganglion cell–inner plexiform layer (GC–IPL) might serve as a biomarker for the response to treatment. Aim The aim of this study was to evaluate the effect of intravitreal injections of Aflibercept on the average thicknesses of the GC–IPL in naïve eyes and on the visual acuity in patients with DME. Patients and methods This is a retrospective observational study that included 224 naïve eyes of 224 patients having DME. It compared the changes in the GC–IPL thickness at baseline and after receiving three loading doses of Aflibercept followed by as needed protocol for 12 months. All patients had optical coherence tomography imaging at baseline (with GC–IPL thickness measurement) and at the 12-month visit. The change in GC–IPL thickness was measured and was correlated with best-corrected visual acuity. Results During the study duration, a median of five injections of Aflibercept were given. There was a statistically significant decrease in the posttreatment values of the GC–IPL thickness from 89±13 to 84±14.7 µm (P=0.029). Moreover, a statistically significant association was found between the thickness reduction of the GC–IPL in the central macular area and the best-corrected visual acuity (r=0.9, P=0.005, Pearson coefficient=0.26). Conclusion The results of this study suggest that the reduction in the GC–IPL thickness can be used as a prognostic tool for the response to Aflibercept as it was associated with improved visual acuity.https://journals.lww.com/10.4103/djo.djo_51_24afliberceptanti-vascular endothelial growth factordiabetic macular edemaganglion cell–inner plexiform layerretinal thicknessvisual acuity |
| spellingShingle | Mouna M. Alsaad Amin B. Shehadeh Iyman M. Alsaad Khalid A. Alubous Jehad S. Meqbil Mohammed Z. Qablawi Saif Aldeen S. AIRyalat Rawan A. Elubous Changes of retinal ganglion cell–inner plexiform layer thickness and visual acuity in patients with diabetic macular edema treated with Aflibercept Delta Journal of Ophthalmology aflibercept anti-vascular endothelial growth factor diabetic macular edema ganglion cell–inner plexiform layer retinal thickness visual acuity |
| title | Changes of retinal ganglion cell–inner plexiform layer thickness and visual acuity in patients with diabetic macular edema treated with Aflibercept |
| title_full | Changes of retinal ganglion cell–inner plexiform layer thickness and visual acuity in patients with diabetic macular edema treated with Aflibercept |
| title_fullStr | Changes of retinal ganglion cell–inner plexiform layer thickness and visual acuity in patients with diabetic macular edema treated with Aflibercept |
| title_full_unstemmed | Changes of retinal ganglion cell–inner plexiform layer thickness and visual acuity in patients with diabetic macular edema treated with Aflibercept |
| title_short | Changes of retinal ganglion cell–inner plexiform layer thickness and visual acuity in patients with diabetic macular edema treated with Aflibercept |
| title_sort | changes of retinal ganglion cell inner plexiform layer thickness and visual acuity in patients with diabetic macular edema treated with aflibercept |
| topic | aflibercept anti-vascular endothelial growth factor diabetic macular edema ganglion cell–inner plexiform layer retinal thickness visual acuity |
| url | https://journals.lww.com/10.4103/djo.djo_51_24 |
| work_keys_str_mv | AT mounamalsaad changesofretinalganglioncellinnerplexiformlayerthicknessandvisualacuityinpatientswithdiabeticmacularedematreatedwithaflibercept AT aminbshehadeh changesofretinalganglioncellinnerplexiformlayerthicknessandvisualacuityinpatientswithdiabeticmacularedematreatedwithaflibercept AT iymanmalsaad changesofretinalganglioncellinnerplexiformlayerthicknessandvisualacuityinpatientswithdiabeticmacularedematreatedwithaflibercept AT khalidaalubous changesofretinalganglioncellinnerplexiformlayerthicknessandvisualacuityinpatientswithdiabeticmacularedematreatedwithaflibercept AT jehadsmeqbil changesofretinalganglioncellinnerplexiformlayerthicknessandvisualacuityinpatientswithdiabeticmacularedematreatedwithaflibercept AT mohammedzqablawi changesofretinalganglioncellinnerplexiformlayerthicknessandvisualacuityinpatientswithdiabeticmacularedematreatedwithaflibercept AT saifaldeensairyalat changesofretinalganglioncellinnerplexiformlayerthicknessandvisualacuityinpatientswithdiabeticmacularedematreatedwithaflibercept AT rawanaelubous changesofretinalganglioncellinnerplexiformlayerthicknessandvisualacuityinpatientswithdiabeticmacularedematreatedwithaflibercept |